Pidilite Industries Limited — PPTs, 08-05-2025: Investor Presentation

1. Financial Highlights:

Pidilite reported consolidated net sales of Rs. 3,130 Cr for Q4 FY25, rising 8.3% YoY, backed by 9.8% volume growth. Consumer & Bazaar segment volume grew 8.0%, while B2B saw a strong 16.4% jump. Gross margins expanded 154 bps QoQ due to favorable input costs. EBITDA stayed stable at 20.6%, reaching Rs. 633 Cr (+9.7% YoY). For FY25, revenue increased 6.1% to Rs. 13,094 Cr, with EBITDA margin improving to 23.6% and EBITDA growing 11.3% to Rs. 3,013 Cr. Domestic subsidiaries showed double-digit sales and EBITDA growth; international sales were flat.

2. Strategic Initiatives & Growth Drivers:

The company maintains aggressive investment in advertising and sales promotion at 5.4% of net sales to drive volume-led growth. Focus areas include brand building, supply chain improvements, and talent development. Growth prospects are supported by a recovering construction sector and anticipated government infrastructure spending.

3. Business Developments:

No major acquisitions or partnerships announced. The focus remains on strengthening core products and expanding subsidiary footprints.

4. Market Position & Competitive Advantage:

Pidilite enjoys leadership in adhesives and specialty consumer products with a wide portfolio of 6,200+ SKUs including strong brands like Fevicol and Dr. Fixit. Scale benefits and deep rural-urban distribution support consistent margin expansion, reflecting procurement and operational efficiencies.

5. Investor Implications:

Solid volume growth, margin improvement, and robust brand presence indicate positive growth potential. Execution on B2B demand recovery and input cost management will be key. Continued high advertising spend signals focus on market share gains. Overall, fundamentals show resilience despite macroeconomic challenges.